Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial

Published:2017-01-19 Issue:1 Volume:17 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

An Jihyun,Lim Young-Suk,Kim Gi-Ae,Han Seong-bong,Jeong Wonhee,Lee Danbi,Shim Ju Hyun,Lee Han Chu,Lee Yung Sang

Funder

Novartis

Korean National Health Clinical Research (NHCR) Project, Ministry of Health and Welfare

Korean Health Technology R and D Project, Ministry of Health and Welfare

Proteogenomic Research Program through the National Research Foundation of Korea funded by the Korea government

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-017-0572-2.pdf

Reference29 articles.

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.

2. Schiff ER. Prevention of mortality from hepatitis B and hepatitis C. Lancet. 2006;368:896–7.

3. Chang TT, Lai CL, Yoon SK, Lee SS, Coelho HS, Carrilho FJ, et al. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2010;51:422–30.

4. Kitrinos KM, Corsa A, Liu Y, Flaherty J, Snow-Lampart A, Marcellin P, et al. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59:434–42.

5. Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, et al. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut. 2014;63:1325–32.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detecting Early Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Using Longitudinal α-Fetoprotein Screening;Clinical Gastroenterology and Hepatology;2022-08

2. Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis;PLOS ONE;2021-12-16

3. Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment;Antiviral Research;2021-11

4. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis;Expert Review of Anti-infective Therapy;2020-05-12

5. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review;Journal of Gastroenterology;2020-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3